MedTrace Logo

Tracking Results of Ablations to Combat AF Registry Generation 2

NCT05111015 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2026-01-07

No results posted yet for this study

Summary

The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.

Conditions

Interventions

DEVICE

Open Concomitant Surgical Ablation Procedures

AtriCure's Open Concomitant Surgical Ablation Devices used for the management of Atrial Fibrillation.

DEVICE

Hybrid (Convergent) Ablation Procedures

AtriCure's Hybrid (Convergent) Ablation Devices used for the management of Atrial Fibrillation.

DEVICE

AtriCure Hybrid Totally Thoracoscopic Ablation Procedures

AtriCure's Hybrid Totally Thoracoscopic Surgical Ablation Devices used for the management of Atrial Fibrillation.

DEVICE

AtriCure LAA Exclusion Procedures

AtriCure's LAA Exclusion Devices used to exclude the Left Atrial Appendage for the management of Atrial Fibrillation.

Sponsors & Collaborators

  • AtriCure, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2030-01-31
Completion
2030-01-31
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05111015 on ClinicalTrials.gov